Asia Fresh News

Asia Fresh Stories

Archive for June 6th, 2013

Mobily Selects NetComm Wireless to Supply M2M Devices

leave a comment »

SYDNEY /PRNewswire/ — NetComm Wireless Limited (ASX: NTC) today announced that it has entered into its second major M2M supply agreement with Etihad Etisalat (Mobily), a leading telecommunications service provider in the Kingdom of Saudi Arabia. The deal is expected to bolster vertical sector opportunities in the Middle East by enabling Machine-to-Machine (M2M) communications over 3G networks as mobile penetration tops 100 per cent.
The phenomenal uptake of mobile broadband communications in the Middle East is fueled by the strong demand for wireless M2M communications across industry sectors such as utilities, oil and gas and transport and other businesses located in areas with limited access to fixed line (ADSL, cable, fibre) services. With new mobile subscriptions in the region growing by 44.1% annually, it is expected that there will be 352 million mobile subscriptions (Informa Telecoms & Media) and 119.7 million wireless M2M connections (Visiongain, 2011) by the end of 2016 as utility meters, vehicles, construction equipment and medical devices become connected.
Etisalat has secured a place in Machina Research’s M2M Leaderboard, a ranking of the top 20 global mobile network operators (MNOs) based on their expected revenue from mobile M2M in 2020, thereby gaining recognition as a world leader in M2M communications and a key driver of large-scale M2M growth throughout the Middle East.
“This M2M supply deal builds on the success of our existing partnership with Mobily and we are pleased to work together to provide countless vertical sectors throughout the Kingdom with significant new opportunities by combining Mobily’s advanced broadband network capabilities with our innovative wireless M2M technologies,” said David Stewart, CEO and Managing Director, NetComm Wireless.
“The rapid expansion of Mobily’s broadband networks, which cover most of the populated areas in the country, has led us to sign this agreement with NetComm Wireless to provide advanced solutions to cover many regions of the kingdom and to support and guarantee business continuity,” said Dr Marwan Al-Ahmadi, CEO, Mobily.
The Indoor Industrial Router with Voice seamlessly integrates with existing applications to provide undisrupted wireless speeds of up to 21Mbps over 3G networks; while also offering analogue telephone connectivity for complete landline replacement.
The Outdoor Industrial Router extends wireless M2M benefits to businesses located in weak or inconsistent 3G signal strength areas. Designed to create a far-reaching indoor and outdoor 300Mbps WiFi network, the IP67 rated Outdoor Routerendures harsh environmental conditions and comes equipped with external 3G and WiFi antennasto ensure an optimal signal in remote regions.
Enquiries to: Stephanie Wilson, NetComm Wireless Communications Manager
Phone: +61 2 9424 2045 or email:
About Mobily
Etihad Etisalat (Mobily) was established in 2004 by a consortium led by Etisalat, the UAE based telecom conglomerate. Mobily is the official brand name of Etihad Etisalat, renowned as the second mobile service provider in the Kingdom of Saudi Arabia. Mobily is the 1st Saudi communications company to get an operation license for 3rd generation services and beyond. In December 2004, Mobily was listed on Tadawul Stock Exchange. Today, Mobily equates to 40%+ market share of the mobile subscriptions in the Kingdom. In March 2008, Mobily was granted approval by CITC (Communication and Information Technology Commission) to acquire Bayanat al-Oula, which was a licensed Data Service Provider for a price of SAR 1.5 Billion. And, in November 2008, Mobily acquired absolute majority stakes in Zajil, the leading Saudi ISP (Internet Service Provider).
Mobily owns vast majority shares in the Saudi National Fiber Network (SNFN) composed with 12,800 KM of structured fiber cable, panned into 7 fully protected rings covering 35 Saudi cities plus access to 60 major hub sites for telecommunications prime points of presence, and complimented with 20 inter-metropolis fiber loops in major Saudi cities. Furthermore, Mobily is a lead investor in prime global submarine cable projects that are expected to be operational in the near future.
About NetComm Wireless
NetComm Wireless Limited (ASX: NTC) is a leading developer of innovative broadband products sold globally to major telecommunications carriers, core network providers and system integrators. For 30 years NetComm has developed a portfolio of world first data communication products, and is arespected global providerof 3G and 4G wireless devices servicing the major telecommunications carrier, Machine-to-Machine (M2M) and Rural Broadband markets. NetComm’s products are designed to meet the growing needs of today’s data-intensive home, business and industrial broadband applications and customized to optimize performance in line with global network advancements. Headquartered in Sydney, Australia, NetComm has offices in New Zealand, North America and the Middle East. For more information about NetComm visit:
Source: NetComm Wireless Limited
Related stocks: Australia:NTC

Written by asiafreshnews

June 6, 2013 at 6:06 pm

Posted in Uncategorized

USGBC to Offer Free LEED Certification to Groundbreaking Projects in New Markets

leave a comment »

WASHINGTON, June 5, 2013 /PRNewswire/ — In an effort to accelerate sustainable development around the world, the U.S. Green Building Council (USGBC), creators of the LEED green building program, announced today — World Environment Day — a new campaign offering free LEED certification to the first green building projects to certify in the 112 countries where LEED has yet to take root.

Coined “LEED Earth,” this campaign aims to bring LEED certification and thereby better-performing buildings into new markets. All building types are welcome to participate across the suite of LEED rating systems.

“LEED is a global language and can become a catalyst for incremental change toward a sustainable future. USGBC is committed to bringing LEED to every country in the world while continuing to foster innovation and achievement in existing global markets,” said Rick Fedrizzi, President, CEO and Founding Chair, USGBC. “Buildings are the single greatest contributor to greenhouse gas emissions of any sector, and the least costly way to alleviate the environmental stresses of our changing planet. LEED is the tool to get the job done.”

With LEED projects in 140 countries and territories, 1.5 million square feet of construction space earn LEED certification each day, the equivalent of nearly four Empire State Buildings a week. To participate in the program and register a project, contact us at For the campaign’s rules and regulations click here. Share your involvement in the campaign or follow updates on Twitter with hashtag #LEEDEarth.

U.S. Green Building Council (USGBC)

The U.S. Green Building Council (USGBC) is committed to a prosperous and sustainable future through cost-efficient and energy-saving green buildings. USGBC works toward its mission of market transformation through its LEED green building certification program, robust educational offerings, a network of chapters and affiliates, the annual Greenbuild International Conference & Expo, and advocacy in support of public policy that encourages and enables green buildings and communities. For more information, visit, and connect on Weiboand LinkedIn.

Contact: Joe Crea

Source: U.S. Green Building Council

Written by asiafreshnews

June 6, 2013 at 5:37 pm

Posted in Uncategorized

Hatton National Bank Goes Live With LeaseWave(R) from Odessa Technologies

leave a comment »

COLOMBO, Sri Lanka, June 5, 2013 /PRNewswire/ — Hatton National Bank (“HNB”) announces they have gone live with the LeaseWave technology platform from Odessa Technologies, Inc. (“Odessa”). HNB is the largest leasing provider in Sri Lanka, financing vehicles and various other types of equipment to individuals and businesses through a network of 250 branches located throughout the country.

“HNB has continued to rapidly expand its branch network. The ability to originate and service our leasing customers locally is an important part of our value proposition,” says RMP Dayawansa, Assistant General Manager – Personal Financial Services, at Hatton National Bank. “The ability to tightly integrate LeaseWave with our existing web strategy and various surround systems, including our core banking solution, enables us to significantly improve our overall efficiency and provide a seamless experience for our customers.”

“HNB now has 600+ users across 250 branches using LeaseWave in a high-touch retail leasing environment. Consolidating their diverse business onto our platform was indeed challenging. But what really made this implementation interesting for us was automating all the nuances of HNB’s business model while ensuring regulatory compliance,” says AR Vedapuri, Associate Vice President — Projects, at Odessa Technologies. “Our success at HNB is exemplary of LeaseWave’s ability to offer flexibility without compromising the robustness of its controls.”

About Hatton National Bank

Hatton National Bank is a premier private sector commercial bank with a network of over 250 customer centres spread across the length and breadth of Sri Lanka. The Banks history dates back to 1888 where it started as Hatton Bank to help the fledgling tea industry. Today the bank is actively involved in retail banking, corporate banking, international banking, treasury, project financing, working capital financing etc. The bank is considered a leader in the retail banking business with an extensive range of products and services on offer. Hatton National Bank has been awarded by the Asian Banker Magazine as the ‘Best Retail Bank in Sri Lanka’ for its performance in 2007, 2008, 2009, 2010, 2011 & 2012 and recently named as the ‘Bank of the Year in Sri Lanka’ for the year 2012 by The Banker Magazine. Learn more about Hatton National Bank and its services by visiting

About Odessa Technologies, Inc.

Odessa Technologies is a software company exclusively focused on the leasing industry. The company is headquartered in Philadelphia, Pennsylvania and employs a staff of 300 people. Odessa is the developer of the LeaseWave suite of products, a fully integrated browser-based lease and loan management solution, providing an end-to-end origination and portfolio management system for equipment leasing and finance, vehicle leasing and fleet management companies. The LeaseWave suite is specifically engineered to be configurable to accommodate even the most complex business model, as evidenced by Odessa’s diverse customer base. Learn more about Odessa Technologies, Inc. and its services by visiting

Written by asiafreshnews

June 6, 2013 at 5:19 pm

Posted in Uncategorized

Actiontec Launches World’s First Receiver for Intel(R) WiDi v4.1

leave a comment »

— Wireless Display Receiver, ScreenBeam Pro, delivers Intel WiDi 4.1 and Miracast experience on any HD Display

SUNNYVALE, California, June 5, 2013 /PRNewswire/ — Actiontec Electronics today launched the first wireless display receiver for Intel WiDi 4.1 for 4th Generation Intel Core Processor Based Systems, enabling users with an Intel WiDi or Miracast-certified device to beam their screens to their big screen HDTV in real-time—with a single touch.


“Actiontec’s ScreenBeam Pro Receiver is a great solution for bringing the full Intel WiDi experience to any HD display,” said Kerry Forell, Intel WiDi Product Line Manager at Intel. “Intel WiDi on a system with a 4th Gen Intel Core processor offers consumers unprecedented ease in sharing all the things they love. Together with Actiontec, we’re showcasing the future of wireless display, where consumers can stream their favorite content to their screen of choice.”

Intel WiDi v4.1 features full HD 3D wireless display video streaming with significantly lower latency than previous generations—for immersive, real-time viewing experiences. It also supports touch to beam, multitasking, and dual-screen enabled apps, so consumers can share content effortlessly, with the swipe of a finger, and use their device as a second screen or independently.

ScreenBeam Pro takes this experience even further—bringing Intel WiDi 4.1 to any HD display. This tiny wireless display receiver—smaller than a deck of cards—connects via HDMI and allows consumers to beam, swipe, mirror, and manipulate their content on whatever screen they choose.

This means that consumers don’t have to buy a new TV or projector to experience the speed and interactivity of the latest wireless display technology. ScreenBeam Pro attaches to existing HD displays and makes them the center of home entertainment.

ScreenBeam Pro is compatible with new Ultrabook™ devices based on 4th generation Intel® Core processors running Intel WiDi v4.1 as well as Intel WiDi v3.5, and Wi-Fi CERTIFIED Miracast™ smartphones and tablets. It’s also HDMI-certified, ensuring the highest level of compatibility with HDTVs, projectors, and displays.

ScreenBeam Pro Highlights

– The world’s receiver for Intel WiDi v4.1
– 1080p HD video
– Full support Intel WiDi 4.1 – including low latency, touch to beam, USB devices
– Compatible with all WiFi CERTIFIED Miracast devices
– HDMI certified
– Price: $69.99
– Availability: In most major markets through select retailers or

“Intel WiDi 4.1 is a game changer for consumers—an incredibly simple way to view laptop and mobile content on any screen, wirelessly,” said Dean Chang, Actiontec’s CEO. “ScreenBeam Pro is at the leading edge of this experience, joining Intel’s expertise in display technology with Actiontec’s leadership in the connected home to give instant access to mobile content on the best display. This wireless display receiver moves entertainment, gaming, personal content—when you want it, where you want it.”

ScreenBeam Pro is the latest product in Actiontec’s award-winning line of wireless display adapters. It is based on the groundbreaking ScreenBeam wireless display platform that won the 2013 Gold Edison Award for innovation in connectivity. For more information on how to free your content, visit:

About 4th Gen Intel WiDi

Intel WiDi 4.1 offers significant performance improvements over prior WiDi generations, including lower latency, stereoscopic 3D 1/2 resolution support, HDCP 2.1, along with smoother video, better color and image quality. In addition, ScreenBeam Pro and Intel WiDi 4.1 both support USB over wireless, allowing users to remotely control content on the TV via a keyboard and mouse. For more information on Intel WiDi, please visit .

About Actiontec Electronics

Actiontec Electronics develops broadband-powered solutions that connect people to the Internet, applications, and content they care about. Our products – including gigabit Ethernet fiber routers, high speed VDSL gateways, DSL modems, and home networking solutions like network adapters, wireless video and display devices – are deployed by some of the largest broadband carriers in North America, and sold in major retail and online stores globally. We listen to our customers, delivering future-proof solutions that help them make connections today and tomorrow, with faster access rates, advanced performance, and exciting applications. Our innovation has been recognized throughout the industry, with numerous awards. As a minority owned company, we’re committed to the world we live in by promoting diversity among our employees and partners, and actively pushing a variety of green programs designed to reduce the carbon footprint of our company, and customers. Founded in 1993, Actiontec is headquartered in Sunnyvale, CA, and maintains branch offices in Colorado Springs, CO; Shanghai, Mainland China; and Taipei, Taiwan.

For more information, call +1-408-752-7700 or visit

Source: Actiontec Electronics

Written by asiafreshnews

June 6, 2013 at 5:10 pm

iConf Presented at the 16th China Beijing International High-tech Expo

leave a comment »

BEIJING /PRNewswire/ — Arkadin, the world leader for providing collaboration solutions and services, announced that “iConf”, the remote conferencing service launched jointly by Arkadin GCT and Beijing Unicom was exhibited at the 16th China Beijing International High-tech Expo (CHITEC) held on 21st to 26th of May. On May 23rd,
“The Chinese Government is advocating the State Owned Enterprises (SOE) to be more energy saving, environmental and conservation friendly, less travel and entertainment spending. iConf is best serving for this purpose. We are very encouraged that more and more SOE including China Life, COFCO, PICC and SINOPHARM are adopting iConf,” the Founder and President of Arkadin GCT China, Mr. Nelson Wu, commented.
The China Beijing International High-Tech Expo (CHITEC) is a major national hi-tech expo that takes place every May in Beijing. It is an event approved by China’s State Council, sponsored by China’s Ministry of Science and Technology, Ministry of Commerce, Ministry of Education, Ministry of Industry and Information Technology (formerly known as Ministry of Information Industry), China Council for the Promotion of International Trade (CCPIT), State Intellectual Property Office and the city government of Beijing, and organized by the Beijing Council for the Promotion of International Trade.
About “iConf”
Beijing Unicom’s collaboration product offering:
iConf Audio-On demand audio conferencing available 24/7 designed for frequent, regular or last-minute meetings and can be accessed worldwide.
iConf Web-Web conferencing and collaboration tool for reaching geographically dispersed audiences with multimedia content.
iConf Event-Pre-scheduled, professionally managed, operator assisted audio and web conferencing service that offers a wide range of features, including Q&A sessions, conference recordings and call transcriptions.
Source: Arkadin

Written by asiafreshnews

June 6, 2013 at 3:38 pm

Posted in Uncategorized

CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A

leave a comment »

— Results of Part 1 of the study will be presented at the 2013 International Society on Thrombosis and Haemostasis in Amsterdam, Netherlands on 2 July, 2013

KING OF PRUSSIA, Pennsylvania, June 4, 2013 /PRNewswire/ — CSL Behring has dosed the first patient in Part 3 of its AFFINITY clinical trial program, which is now in phase III. AFFINITY is an open-label, non-randomized, multi-center study evaluating the efficacy, safety and pharmacokinetics of its novel investigational recombinant coagulation single-chain factor VIII (rVIII-SingleChain) for the treatment of hemophilia A. The patient was dosed in Vienna, Austria and had a successful major surgery.

The CSL Behring rVIII-SingleChain is a novel recombinant single-chain Factor VIII design that uses a strong, covalent bond that has been shown to improve the stability and half-life of factor VIII (FVIII). A recombinant factor therapy option with a longer half-life could provide a longer dosing interval, leading to less frequent injections. This may have the potential to improve compliance and ease prophylaxis, improving the quality of life for people with hemophilia A.

“We are proud and excited that this recombinant coagulation factor development program is progressing into Phase III clinical studies and look forward to sharing the clinical trial results for our novel rVIII-SingleChain molecule with the hemophilia community in the future,” said Russell Basser, M.D., CSL Senior Vice President, Global Clinical Research & Development. “As part of our ongoing commitment to the hemophilia community, we are developing and investigating innovative recombinant factor therapies for the treatment of both hemophilia A and B that have the potential to offer patients and caregivers significant advances in treatment and convenience of factor infusion.” CSL Behring, in collaboration with its parent company, CSL Limited (ASX: CSL), is developing rVIII-SingleChain through the AFFINITY clinical trial program.

About the AFFINITY Phase I/III Study
The Phase I/III study is an open-label, multi-center trial that examines the crossover safety, efficacy and pharmacokinetics of recombinant coagulation single-chain factor VIII compared with recombinant human antihemophilic factor VIII (octocog alpha).

In Part 1 of the study, 27 subjects received a single infusion of 50 IU/kg body weight (b.w.) of octocog alfa followed by a single infusion of 50 IU/kg b.w. rVIII-SingleChain. Results of Part 1 of the study will be presented at the 2013 International Society on Thrombosis and Haemostasis in Amsterdam, Netherlands on 2 July. In Parts 2 and 3 of the study, subjects will receive infusions of rVIII-SingleChain to prevent and treat bleeding (if required), at a dose and frequency determined by their study doctor (based on the subject’s underlying bleeding phenotype). More information about the study design can be found at

Recombinant FVIII molecules so far available consist of a heavy and a light chain. Under certain conditions, these chains can dissociate, resulting in the formation of separated, or “dissociated,” rFVIII chains that are not hemostatically active. The CSL Behring rVIII-SingleChain uses a strong, covalent bond that connects the light and heavy chains, thereby creating a stable single chain rFVIII.

In-house studies have shown that the molecular integrity of rVIII-SingleChain is significantly increased using the single-chain design, resulting in a homogenous product that is more stable than currently available FVIII products. In addition, in-vitro studies have shown that rVIII-SingleChain demonstrates a strong affinity for von Willebrand factor (VWF), resulting in a faster and more efficient binding to VWF. The FVIII/VWF complex plays an important role in the physiological activity and clearance of FVIII and has been shown to have an influence on the presentation of FVIII to the immune system.

The research leading to the initiation of the studies that CSL Behring is now conducting is the result of collaboration across the CSL Behring research sites in Marburg, Germany, in King of Prussia, USA, and at laboratories operated by CSL Limited in Melbourne, Australia.

About Hemophilia
Hemophilia is a congenital bleeding disorder characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. In nearly all cases, it affects only males. The disease is caused by deficient or defective blood coagulation proteins known as factor VIII or IX (FIX). The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective. Hemophilia B is characterized by deficient- or defective factor IX. Hemophilia A affects approximately 1 in 5,000 to 10,000 people. Hemophilia B affects approximately 1 in 25,000 to 50,000 people. The recommended treatment for patients who are factor deficient is to treat by replacement factor therapy.

About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.

CSL Behring therapies are used around the world to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders in certain markets. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited (ASX: CSL), a biopharmaceutical company headquartered in Melbourne, Australia. For more information, visit

Media Contact:

Sheila Burke
Director, Public Relations & Communications
Worldwide Commercial Operations

Source: CSL Behring

Written by asiafreshnews

June 6, 2013 at 3:23 pm

Prolexic Releases Free DDoS Protection Planning Tool to Help Organizations Build Stronger Defenses

leave a comment »

— PLXplanner 2.0 available now at

HOLLYWOOD, Fla., June 4, 2013 /PRNewswire/ — Prolexic, the global leader in Distributed Denial of Service (DDoS) protection services, announced today that it has released a role-based version of PLXplanner, the company’s free, online DDoS protection planning tool. PLXplanner is a strategic risk assessment and planning tool to help IT and security professionals build a better defense against increasingly powerful and sophisticated DDoS attacks. Based on answers entered in a role-based quiz, PLXplanner delivers strategic recommendations for improving business, technology or operational strategies to fight DDoS attacks.

“Organizations need to realize that DDoS attacks are not just a technology problem,” said Stuart Scholly, president at Prolexic. “There are several dimensions to building a strong defense against these attacks. PLXplanner helps organizations focus on areas that are typically overlooked when evaluating their DDoS vulnerabilities.”

Last year, Prolexic introduced the industry’s most detailed DDoS Downtime Calculator. Since then Prolexic has reworked and refocused the online tool to deliver more strategic value. Renamed PLXplanner, the tool now delivers specific DDoS defense guidance and best-practice recommendations rather than bottom line numbers.

The operations planner, for example, asks questions about security architecture, application testing, monitoring capabilities, web team availability and more.

If your company already has website availability monitoring in place, PLXplanner will recommend including synthetic transactions, such a login to a test account. Why? Because an attacker can target back-end databases via HTTP application attacks (such as a POST attack). In that case, the website may appear to be online even though users cannot log in.

“PLXplanner 2.0 is a much deeper, more valuable tool. Our detailed recommendations reflect the user’s unique IT and networking environment, customized to their role and responsibilities. This makes it more relevant and valuable for users at every level of the organization,” added Scholly.

PLXplanner is available at

About Prolexic

Prolexic is the world’s largest, most trusted Distributed Denial of Service (DDoS) mitigation provider. Able to absorb the largest and most complex attacks ever launched, Prolexic restores mission-critical Internet-facing infrastructures for global enterprises and government agencies within minutes. Ten of the world’s largest banks and the leading companies in e-Commerce, SaaS, payment processing, travel/hospitality, gaming and other at-risk industries rely on Prolexic to protect their businesses. Founded in 2003 as the world’s first in-the-cloud DDoS mitigation platform, Prolexic is headquartered in Hollywood, Florida and has scrubbing centers located in the Americas, Europe and Asia. To learn more about how Prolexic can stop DDoS attacks and protect your business, please, follow us on LinkedInFacebookGoogle+,YouTube,and @Prolexic on Twitter.

Michael E. Donner
SVP, Chief Marketing Officer
media {at} prolexic {dot} com

Source: Prolexic Technologies

Written by asiafreshnews

June 6, 2013 at 2:38 pm

Zydus Pioneers a Breakthrough With LIPAGLYN, India’s First NCE to Reach the Market

leave a comment »

MUMBAI, India, June 5, 2013 /PRNewswire/ —

Lipaglyn™ is the first Glitazar to be approved in the world and the first NCE discovered and developed indigenously by an Indian Pharma Company.

The Zydus Group announced a breakthrough in its research efforts with Lipaglyn™ (Saroglitazar), a novel drug targeted at treating Diabetic Dyslipidemia or Hypertriglyceridemia in Type II diabetes, not controlled by statins alone. The drug has been approved for launch in India by the Drug Controller General of India (DCGI). With a novel action that offers lipid and glucose lowering effects in one molecule, Lipaglyn™ is the first Glitazar to be approved anywhere in the world.

Diabetic Dyslipidemia is a condition where a person is diabetic and has elevated levels of the total cholesterol, the “bad” low-density lipoprotein (LDL) cholesterol and the triglycerides and a decrease in the “good” high-density lipoprotein (HDL) cholesterol concentration in the blood. Almost 85 to 97% of all diabetics are estimated to suffer from diabetic dyslipidemia. Lipaglyn – a non-thiazolidinedione, is the first therapy to be approved for this condition.

“Lipaglyn™ provides patients suffering from diabetic dyslipidemia the option of a once-daily oral therapy that has a beneficial effect on both lipid parameters as well as glycemic control,” said Mr. Pankaj Patel, Chairman and Managing Director, Zydus Cadila. “It has always been our dream to take a molecule right from the concept stage up to its launch. Today, we have realized this dream. It is an important breakthrough and I would like to dedicate this to all the Indian research scientists in the field of drug discovery,” Mr. Patel added.

Discovered by the Zydus Research Centre, the dedicated NCE research arm of the group, Lipaglyn™ is a best-in-class innovation, designed to have a unique cellular mechanism of action. With a predominant affinity to PPAR alpha isoform and moderate affinity to PPAR gamma isoform of PPAR nuclear receptor subfamily, the molecule has shown beneficial effects on lipids and glycemic control without side effects. The IND was submitted in the year 2004.

The New Drug Application for Lipaglyn™ was based on a comprehensive clinical development programme Phase-I, Phase-II and Phase-III clinical trials, spanning eight years. Results from the first Phase III programme with Pioglitazone as a comparator drug in diabetes patients showed that the 4 mg dose of Lipaglyn™ led to a reduction of triglycerides and LDL cholesterol, and an increase in HDL cholesterol and also showed a reduction in Fasting Plasma Glucose and glycosylated haemoglobin (HbA1c) thereby confirming its beneficial effects of both lipid and glycemic control in diabetic patients. Lipaglyn™ is recommended as 4 mg tablets.

About Zydus Cadila

Zydus Cadila is a global pharmaceutical company headquartered in Ahmedabad, India. The group discovers, develops, manufactures and markets a broad range of healthcare therapies.  With 20 discovery research programmes under various stages of clinical development, the group invests 7% of its turnover on research. The Zydus Research Centre has over 400 research scientists engaged in NCE research.

Source: Cadila Healthcare

Written by asiafreshnews

June 6, 2013 at 2:19 pm

Texas Instruments becomes first semiconductor company to install AutoStore(R) automated warehouse system

leave a comment »

— TI’s Singapore Product Distribution Center first of its kind in Asia
SINGAPORE /PRNewswire/ — Further enhancing the efficiency and reliability of its product shipments throughout Asia, Texas Instruments Incorporated (TI) (NASDAQ: TXN) today announced it has installed the AutoStore® inventory management system in its Product Distribution Center (PDC) in Singapore. This marks the first installation of AutoStore by a semiconductor company, as well as the first of its kind in Asia.
AutoStore uses state-of-the-art warehouse automation and reduces the amount of space required for inventory. Goods are stored in bins within an aluminum grid structure, and battery-driven robots move along rails on the top of the grid to store and retrieve product from the bins. The robots deliver requested goods to operator ports along the outside of the grid. TI’s installation of this unique solution will include 63,000 storage bins for TI products.
“At full capacity, the AutoStore system will provide several benefits for TI’s customers, including increased storage and shipping capabilities,” said Jan De Meulder, director of worldwide logistics at TI. “This innovative warehouse automation system will make more inventory readily available to our customers in Asia and improve the efficiency and reliability of our shipments.”
A joint effort between TI and its logistics suppliers, DHL and Swisslog, the newly automated PDC began ramping this week and will be in full production by September.
“This investment demonstrates how companies can deploy material handling solutions to significantly increase efficiency and productivity, enhance competitiveness and up-skill the jobs in the logistics operations. This is also a good example of how the logistics industry in Singapore can continue to transform itself and strengthen its position as a leading global logistics hub,” said Kelvin Wong, Executive Director, Singapore Economic Development Board.
TI commissioned Swisslog to design and implement AutoStore, which includes the grid system, AutoStore software and the light goods conveyor system. An efficient storage and order picking system for single items and small cases, AutoStore is one of the most innovative offerings from Swisslog.
DHL provides complete contract logistics support at TI’s PDC in Singapore and has been integral partner through the design and implementation of AutoStore. By allowing four times the amount of product to be stored within the same footprint, the integrated design will support years of growth in this strategic PDC location.
About TI
Texas Instruments Incorporated (TI) is a global semiconductor design and manufacturing company that develops analog ICs and embedded processors. By employing the world’s brightest minds, TI creates innovations that shape the future of technology. TI is helping more than 100,000 customers transform the future, today. Learn more at
Source: Texas Instruments Incorporated

Written by asiafreshnews

June 6, 2013 at 11:33 am

Posted in Uncategorized

Development of New Technologies Spurs Molecular Diagnostic Test Volumes in Asia-Pacific, Finds Frost & Sullivan

leave a comment »

— Oncology testing likely to be the next key area of focus

KUALA LUMPUR, Malaysia, June 5, 2013 /PRNewswire/ — The Asia-Pacific molecular diagnostics market is poised for rapid growth owing to the high prevalence of diseases, increase in the aged population, economic development, and the rising need for better healthcare services. Although several challenges related to cost, regulations and reimbursement policies exist, the market offers immense opportunities for molecular diagnostics vendors.

New analysis from Frost & Sullivan (, Analysis of the Asia-Pacific Molecular Diagnostics Market, finds that the market earned revenues of more than US$846.5 million in 2012 and estimates this to reach US$2,528.1 million in 2019.

Public awareness on new, cutting-edge technologies and preventive medicine is increasing in several Asia-Pacific countries. Recognition that molecular diagnostics tests are more accurate, cost-effective, and short turnaround time compare to conventional diagnostics has spurred market growth.

“Newer, automated technologies such as microarrays, Real time PCR technology, mass spectrometric proteomic analyses and protein chips have transformed the way physicians detect and diagnose cancers and genetic diseases at an early stage,” said Frost & Sullivan Healthcare Industry Analyst Gulifeiya Abuduxike. “This has also paved the way for personalized medicine, which can identify the predisposition of a patient to a disease based on genetic variants, and target therapy at the right time.”

While these advanced, automated and integrated technologies widen the application scope of molecular diagnostics, they also lead to high test costs, which a huge section of patients in Asia-Pacific are unable to afford.

The lack of healthcare insurance and reimbursement schemes for diagnostics, usually not considered as important as drugs, further limits adoption in the region. The shortage of skilled technicians and insufficient infrastructure adds to the challenge.

Therefore, clinicians and patients must be educated on the medical value and benefit of molecular diagnostics as well as the need for early detection and preventive medicine. Governments need to establish reimbursements for molecular tests to boost test volumes as well as to reduce the treatment costs.

“Expanding testing menus and application areas, as well as developing automated instruments through research and development are also crucial,” noted Gulifeiya. “Molecular diagnostic companies must look to enhance the accuracy of test results and reduce time consumption.”

As focus shifts to oncology testing, pharmacogenomics and the co-development of companion diagnostics will be key business strategies for Asia-Pacific pharmaceutical companies to maximize the cost-effectiveness of cancer drugs.

If you are interested in more information on this research, please send an e-mail to Donna Jeremiah, Corporate Communications, at, with your full name, company name, job title, telephone number, company e-mail address, company website, city, state and country.

Analysis of the Asia-Pacific Molecular Diagnostics Market is part of the Life Sciences Growth Partnership Service program. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation

Analysis of the Asia-Pacific Molecular Diagnostics Market

Donna Jeremiah
Corporate Communications — Asia Pacific
P: +61-(02)-8247-8927
F: +61-(02)-9252-8066

Carrie Low
Corporate Communications — Asia Pacific
P: +603-6204-5910
F: +603-6201-7402
Source: Frost & Sullivan

Written by asiafreshnews

June 6, 2013 at 10:29 am

Posted in Uncategorized